Anika Therapeutics Company Profile (NASDAQ:ANIK)

Analyst Ratings

Consensus Ratings for Anika Therapeutics (NASDAQ:ANIK) (?)
Ratings Breakdown: 2 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $49.50 (0.84% downside)

Analysts' Ratings History for Anika Therapeutics (NASDAQ:ANIK)
Show:
DateFirmActionRatingPrice TargetActions
4/27/2016Northland SecuritiesDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Barrington ResearchBoost Price TargetOutperform$45.00 -> $49.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/27/2015First AnalysisInitiated CoverageEqual -> Equal WeightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/12/2014Singular ResearchLower Price TargetBUY -> Buy$51.50 -> $45.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2014 forward)

Earnings

Earnings History for Anika Therapeutics (NASDAQ:ANIK)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
10/26/2016        
7/27/2016Q216$0.44$0.57$24.75 million$26.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/27/2016Q116$0.28$0.45$19.26 million$22.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2016Q415$0.60$0.72$28.19 million$25.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2015Q315$0.34$0.55$22.36 million$23.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2015Q215$0.34$0.51$21.65 million$22.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2015Q115$0.21$0.23$16.20 million$15.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2015Q414$0.48$0.51$24.60 million$23.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q314$0.33$0.40$20.33 million$22.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2014Q214$0.57$0.60$28.20 million$26.27 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2014Q114$0.25$0.97$16.03 million$34.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2014Q413$0.42$0.44$21.91 million$21.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/31/2013Q313$0.14$0.33$16.96 million$17.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2013Q2 2013$0.25$0.40$17.09 million$20.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Anika Therapeutics (NASDAQ:ANIK)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.19$0.25$0.22
Q2 20162$0.38$0.47$0.43
Q3 20162$0.38$0.46$0.42
Q4 20162$0.41$0.47$0.44
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Anika Therapeutics (NASDAQ:ANIK)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Anika Therapeutics (NASDAQ:ANIK)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/25/2016Raymond J LandDirectorSell2,695$43.62$117,555.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/27/2015Raymond J LandDirectorSell4,621$39.49$182,483.29View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2014Charles H SherwoodCEOSell83,780$44.32$3,713,129.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/28/2014Charles H SherwoodCEOSell200,000$41.70$8,340,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/22/2013John C MoranDirectorSell5,000$24.35$121,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/8/2013Steve E WheelerDirectorSell26,984$23.61$637,092.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2013Steve E WheelerDirectorSell11,016$27.01$297,542.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/6/2013Farmaceutici S.P.A. FidiaMajor ShareholderSell1,270,000$24.52$31,140,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2013Charles H SherwoodCEOSell75,000$20.11$1,508,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/9/2013Charles H SherwoodCEOSell49,185$18.06$888,281.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/5/2013Charles H SherwoodCEOSell34,662$18.01$624,262.62View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2013Charles H SherwoodCEOSell1,847$18.00$33,246.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Anika Therapeutics (NASDAQ:ANIK)
DateHeadline
07/30/16 02:36 PMAnika Therapeutics Inc. (ANIK) is Trading Lower on Unusual Volume for July 28 - Equities.com
07/30/16 02:36 PMAnika Therapeutics Inc. (ANIK) Drops 6.39% on July 28 | Equities.com - Equities.com
07/29/16 02:31 PMNew Broker Ratings For Anika Therapeutics Inc. (NASDAQ:ANIK ... - FTSE News
07/28/16 09:11 PMLatest report: global non surgical bio implants market 2015 industry trends, demand, share, research, analysis 2022
07/28/16 11:12 AMAnika Therapeutics Inc.: Anika Reports Second Quarter 2016 Financial Results - The Wall Street Transcript
07/28/16 08:00 AMAnika Therapeutics Inc Earnings Call scheduled for 9:00 am ET today -
07/27/16 08:16 PMEurope Viscosupplementation Market Will Reach at a CAGR of 5.1% from 2016 to 2026
07/27/16 08:16 PMGlobal Market for Regenerative Medicine & Stem Cells - What’s hot, what’s not, what’s next by 2019?
07/27/16 08:16 PMAnika Reports Second Quarter 2016 Financial Results
07/27/16 08:16 PMAnika Therapeutics : beats 2Q profit forecasts
07/27/16 04:59 PMAnika beats 2Q profit forecasts -
07/27/16 10:44 AMCan Shares Of Anika Therapeutics Inc. (NASDAQ:ANIK) Hit $60? - Investor Newswire
07/27/16 06:07 AMQ2 2016 Anika Therapeutics Inc Earnings Release - After Market Close -
07/20/16 09:58 PMRegenerative Medicine & Stem Cells - Whatâ s hot, whatâ s not, whatâ s next by 2020?
07/20/16 09:58 PMIntuitive Surgical : Top Medical Companies Reach High Financial Strength
07/20/16 10:37 AMAccounts Payable For Anika Therapeutics Inc. (NASDAQ:ANIK) Stood At $3.263 - RealistInvestor.com
07/19/16 02:30 PMCapital Management Corp Increased Anika Therapeutics INC (NASDAQ:ANIK) by $5.17 Million as Shares Rose - Consumer Eagle
07/19/16 02:30 PMAnika Therapeutics Inc versus Endologix Inc Head to Head Compare - CML News
07/19/16 10:58 AMETF’s with exposure to Anika Therapeutics, Inc. : July 19, 2016 -
07/19/16 08:41 AMIs $60 Price Target Attainable For Anika Therapeutics Inc. (NASDAQ:ANIK)? - Investor Newswire
07/18/16 02:33 PMHealthinvest Partners Ab Increased Anika Therapeutics INC (NASDAQ:ANIK) by $4.91 Million as Shares Rose - Consumer Eagle
07/18/16 07:20 AMHow Analysts Rated Anika Therapeutics Inc (NASDAQ:ANIK) Last Week? - Consumer Eagle
07/18/16 07:20 AMShare Performance Summary for: Anika Therapeutics Inc. (NASDAQ:ANIK) - Press Telegraph
07/16/16 10:53 AMAnika Therapeutics Incorporated (NASDAQ:ANIK) Shorted Shares Decreased By 4.79% - Press Telegraph
07/15/16 06:46 PMAnika to Issue Second-Quarter 2016 Financial Results and Business Highlights on Wednesday , July 27
07/15/16 01:05 PMFacial Rejuvenation Market Overviews and Complete Forecast Report
07/14/16 02:32 PMAnika Therapeutics Inc Realized Volatility Hits Substantially Low Level - CML News
07/13/16 07:59 PMAnika Therapeutics : to Issue Second-Quarter 2016 Financial Results and Business Highlights on Wednesday, July 27
07/13/16 03:38 PMAnika to Issue Second-Quarter 2016 Financial Results and Business Highlights on Wednesday, July 27 - [at noodls] - 349c30fc-522e-4dd3-9c45-b4eb462953fb.pdf July 13, 2016 BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its second-quarter 2016 ...
07/13/16 02:30 PMNew Broker Ratings For Anika Therapeutics Inc. (NASDAQ:ANIK) - FTSE News
07/13/16 08:23 AMHere's Whats Next for Anika Therapeutics Post-Breakout -
07/12/16 06:46 AMStrong Sell Calls For Anika Therapeutics Inc. (NASDAQ:ANIK) At 0 - Investor Newswire
07/11/16 07:18 AMStock on the Rise for the Quarter: Anika Therapeutics Inc. (NASDAQ:ANIK) - Engelwood Daily
07/11/16 07:18 AMShare Valuation Recap for: Anika Therapeutics Inc. (NASDAQ:ANIK) - Telanagana Press
07/11/16 07:18 AMStock Performance Rundown on: Anika Therapeutics Inc. (NASDAQ:ANIK) - Press Telegraph
07/10/16 07:15 AMAre Analysts Bullish Anika Therapeutics Inc (NASDAQ:ANIK) After Last Week? - Engelwood Daily
07/09/16 10:36 AMAnika Therapeutics Incorporated (NASDAQ:ANIK) Sellers Covered 4.79% of Their Shorts - Press Telegraph
07/08/16 02:32 PMAnika Therapeutics Inc. (ANIK) is Trading Lower on Unusual Volume for July 06 - Equities.com
07/08/16 10:33 AMAnti-Adhesion Products Market Share Shows Highest Revenue in North America Approved by FDA 2016- TMR Report
07/07/16 07:46 PMAnika Therapeutics Inc. (NASDAQ:ANIK) Expected To Post Sales Of $114.76 - Investor Newswire
07/07/16 10:27 AMAnika Therapeutics Inc. (ANIK) is Trading Lower on Unusual Volume for July 05 - Equities.com
07/06/16 08:16 PMShort Information Review for: Anika Therapeutics Inc. (NASDAQ:ANIK) - Engelwood Daily
07/06/16 08:16 PMBrokers Issue Average Price Target Of 55.75 On Anika Therapeutics Inc. (NASDAQ:ANIK) - Fiscal Standard
07/06/16 07:20 AMAccounts Payable For Anika Therapeutics Inc. (NASDAQ:ANIK) Reach $3.263 - RealistInvestor.com
07/05/16 02:29 PMShares Entering Overbought Range: Anika Therapeutics Inc. (NASDAQ:ANIK) - Press Telegraph
07/05/16 07:16 AMNews Buzz: Anika Therapeutics Inc. (NASDAQ:ANIK), Advanced Micro Devices, Inc. (NASDAQ:AMD), TherapeuticsMD ... - KC Register
07/04/16 02:28 PMShares With YTD Gains: Anika Therapeutics Inc. (NASDAQ:ANIK) - Telanagana Press
07/04/16 02:28 PMShare Performance Recap for: Anika Therapeutics Inc. (NASDAQ:ANIK) - Press Telegraph
07/04/16 07:18 AMAnika Therapeutics Inc. (NASDAQ:ANIK) Broker Price Targets For The Coming Week - Fiscal Standard
07/03/16 07:16 AMStock Valuation in Review: Anika Therapeutics Inc. (NASDAQ:ANIK) - Telanagana Press

Social

About Anika Therapeutics

Anika Therapeutics logoAnika Therapeutics, Inc. develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. The Company's products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body. The Company's wholly owned subsidiary Anika S.r.l., has about 20 products commercialized primarily in Europe. These products are also all made from HA, based on two technologies: HYAFF, which is a solid form of HA and ACP gel, an autocross-linked polymer of HA. The Company's technologies for modifying the HA molecule allow product properties to be tailored specifically to therapeutic use. The Company offers therapeutic products from these technologies in the areas of: Orthobiologics, Dermal (Advanced wound care and Aesthetic dermatology), Surgical (Anti-adhesion and Ear, nose and throat care (ENT)), Ophthalmic and Veterinary.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: ANIK
  • CUSIP: 03525510
Key Metrics:
  • Previous Close: $49.22
  • 50 Day Moving Average: $51.55
  • 200 Day Moving Average: $45.42
  • P/E Ratio: 21.79
  • P/E Growth: 1.81
  • Market Cap: $737.67M
  • Beta: 1.6
  • Current Year EPS Consensus Estimate: $1.80 EPS
  • Next Year EPS Consensus Estimate: $1.94 EPS
Additional Links:
Anika Therapeutics (NASDAQ:ANIK) Chart for Saturday, July, 30, 2016